Effectiveness and Tolerability of First-Line Afatinib for Advanced EGFR-Mutant Non-Small Cell Lung Cancer in Vietnam

BACKGROUND: We aimed to evaluate the effectiveness and tolerability of Afatinib as first-line treatment of advanced epidermal growth factor receptor (EGFR) mutant non small cell lung cancer (NSCLC) in a real-world setting. PATIENTS AND METHODS: This is a retrospective study of Vietnamese patients wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Vu, Thanh Ha, Nguyen, Hoa Thai Thi, Dao, Linh Khanh, Duong, Chi Khanh, Nguyen, Cao Van, Doan, Tuyet Thi, Nguyen, Hang Thuy Thi, Hoang, Hung Huy, Dinh, Dung Khac, Le, Giang Vinh, Vu, Thanh Thi, Truong, Minh Cong, Nguyen, Long Thanh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8408372/
https://www.ncbi.nlm.nih.gov/pubmed/34048189
http://dx.doi.org/10.31557/APJCP.2021.22.5.1581

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8408372/
https://www.ncbi.nlm.nih.gov/pubmed/34048189
http://dx.doi.org/10.31557/APJCP.2021.22.5.1581

Ejemplares similares